Cite
HARVARD Citation
Streffer, J. et al. (n.d.). O1–06–02: Effect of bapineuzumab on CSF p‐tau and t‐tau in mild‐to‐moderate Alzheimer's disease: Results from two phase III trials in APOE‐ε4 carriers and noncarriers. Alzheimer's & dementia. p. P138. [Online].